RIF1 and central nervous system cancer: GP130, low-density lipoprotein receptor-related protein 12 (LRP12), and Rap1 interacting factor 1 (RIF1), as candidate palmitoylated proteins for experimental validation, may be associated with glioma development and malignant progression (Fig. 4b).